Skelly 2005.
Methods |
Parallel randomised controlled clinical trial (RCT) Randomisation ratio: 23 intervention:18 control Superiority design |
|
Participants |
Inclusion criteria:
Exclusion criteria:
Diagnostic criteria: not stated Participating population: older African American women in rural area in North Carolina |
|
Interventions |
Number of study centres: One health department; two community‐based practices; one community health centre providing primary care in 3 rural counties of a southeastern state Treatment before study: not stated Intervention: individual biweekly visits to individuals' homes lasting < 1 hour, with 4 achievable modules on teaching and counselling intervention based on patient‐nurse collaboration. Total time spent with participants was 6 hours. Provider was a nurse‐investigator not blinded to participants' group assignment Control: Control group received also 2 pre‐intervention visits, during which demographic data were collected and study instruments administered. Controls also received a telephone call at a midpoint between baseline and final evaluation details. Total time spent was 3 hours and time spent on a telephone call Provider: nurse |
|
Outcomes |
Outcomes reported in abstract of publication: Primary outcome(s):
Secondary outcome(s): Not stated primary or secondary outcomes |
|
Study details |
Run‐in period: not stated Study terminated before regular end: no |
|
Publication details |
Language of publication: English Funding: National Institute of Nursing Research Grant Publication status: peer‐reviewed journal |
|
Stated aim of study | Quote from publication: "To assess the effect of culturally sensitive symptoms‐focused intervention in older African‐American women with type 2 DM in a rural area" | |
Notes | ‐ | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Comment: used random tables |
Allocation concealment (selection bias) | Unclear risk | Comment: no mention |
Blinding of participants and personnel (performance bias) Objective outcomes | High risk | Comment: participants and providers not blinded |
Blinding of participants and personnel (performance bias) Subjective outcomes | Unclear risk | Comment: no subjective outcomes used in data analysis |
Blinding of outcome assessment (detection bias) Lab tests: Lipids, HBA1C | Low risk | Comment: outcome assessors not blinded but unlikely to have affected HbA1c |
Blinding of outcome assessment (detection bias) Subjective outcomes | Unclear risk | Comment: no subjective outcomes used in data analysis |
Incomplete outcome data (attrition bias) Objective outcomes | Unclear risk | Comment: not stated whether ITT used. 4 of 47 lost to follow‐up. Few reasons given |
Incomplete outcome data (attrition bias) Subjective outcomes | Unclear risk | Comment: no subjective outcomes used in data analysis |
Selective reporting (reporting bias) | Unclear risk | Comment: protocol not seen |
Other bias | Unclear risk | Comment: none |